Last updated on June 2018

Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)

Brief description of study

The purpose of the study is to evaluate the long-term safety and tolerability of SHP465 at 6.25 milligram (mg) in children aged 4 to 12 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).

Clinical Study Identifier: NCT03325894

Contact Investigators or Research Sites near you

Start Over

Scott Segal

Scientific Clinical Research, Inc.
North Miami, FL United States
  Connect »

Armando Acevedo

Acevedo Medical Group
Miami, FL United States
  Connect »

Amol Malankar

Care Research Center
Doral, FL United States
  Connect »

Maria A. Carballosa

Power MD Clinical Research Institute
Hialeah, FL United States
  Connect »